NT-I7 ( DrugBank: NT-I7 )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
25進行性多巣性白質脳症1

25. 進行性多巣性白質脳症


臨床試験数 : 26 薬物数 : 35 - (DrugBank : 22) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 37
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04781309
(ClinicalTrials.gov)
May 5, 20213/3/2021NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal LeukoencephalopathyA Pilot Study of NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal LeukoencephalopathyProgressive Multifocal LeukoencephalopathyDrug: NT-I7National Institute of Neurological Disorders and Stroke (NINDS)NULLRecruiting18 YearsN/AAll12Early Phase 1United States